Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Electric field device shows promise in tough pancreatic cancer trial

NCT ID NCT03377491

Disease control Sponsor: NovoCure Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 trial tested a wearable device called Tumor Treating Fields (TTFields) combined with standard chemotherapy for people with locally advanced pancreatic cancer that cannot be removed by surgery. The device sends low-intensity electric fields to the tumor area to disrupt cancer growth. The study enrolled 571 participants to see if adding TTFields to chemo improves overall survival compared to chemo alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Tumor Treating Fields (TTFields) device plus chemotherapy (gemcitabine and nab-paclitaxel)
What this could lead to
If it works, this could offer a new way to slow or shrink pancreatic tumors, potentially extending life for people with this hard-to-treat cancer.
What could go wrong
This is a phase 3 trial, but results are not yet known. The device adds complexity to treatment, and side effects from the device or chemo may limit benefits. Success is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

571 people

The number who actually took part.

Started

May 2018

Finished

Oct 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. 18 years of age and older 2. Life expectancy of ≥ 3 months 3. Histological/cytological diagnosis of de novo adenocarcinoma of the pancreas 4. Unresectable, locally advanced stage disease according to the following criteria: * Head/uncinate process: 1. Solid tumor contact with SMA\>180° 2. Solid tumor contact with the CA\>180° 3. Solid tumor contact with the first jejunal SMA branch 4. Unreconstructible SMV/PV due to tumor involvement or occlusion (can be d/t tumor or bland thrombus) 5. Contact with most proximal draining jejunal branch into SMV * Body and tail 1. Solid tumor contact of \>180° with the SMA or CA 2. Solid tumor contact with the CA and aortic involvement 3. Unreconstructible SMV/PV due to tumor involvement or occlusion (can be d/t tumor or bland thrombus) * No distant metastasis, including non-regional lymph node metastasis * No borderline resectable (per Al-Hawary MM, et al., Radiology 201414) 5. ECOG score 0-2 6. Amenable and assigned by the investigator to receive therapy with gemcitabine and nab-paclitaxel 7. Able to operate the NovoTTF-200T System independently or with the help of a caregiver 8. Signed informed consent form for the study protocol Exclusion Criteria: 1. Prior palliative treatment (e.g. surgery, radiation) to the tumor 2. Cancer requiring anti-tumor treatment within the 5 years before inclusion, excluding treated stage I prostate cancer, in situ cervical or uterus cancer, in situ breast cancer and non-melanomatous skin cancer. 3. Serious co-morbidities: 1. Clinically significant (as determined by the investigator) hematological, hepatic and renal dysfunction, defined as: Neutrophil count \< 1.5 x 10\^9/L and platelet count \< 100 x 10\^9/L; bilirubin \> 1.5 x Upper Limit of Normal (ULN); AST and/or ALT \> 2.5 x ULN; and serum creatinine \> 1.5 x ULN. 2. History of significant cardiovascular disease unless the disease is well controlled. Significant cardiac disease includes second/third degree heart block; significant ischemic heart disease; poorly controlled hypertension; congestive heart failure of the New York Heart Association (NYHA) Class II or worse (slight limitation of physical activity; comfortable at rest, but ordinary activity results in fatigue, palpitation or dyspnea). 3. History of arrhythmia that is symptomatic or requires treatment. Patients with atrial fibrillation or flutter controlled by medication are not excluded from participation in the trial. 4. History of cerebrovascular accident (CVA) within 6 months prior to randomization or that is not stable. 5. Active infection or serious underlying medical condition that would impair the ability of the patient to receive protocol therapy. 6. History of any psychiatric condition that might impair patient's ability to understand or comply with the requirements of the study or to provide consent. 4. Concurrent anti-tumor therapy beyond gemcitabine and nab-paclitaxel 5. Implantable electronic medical devices in the torso, such as pacemakers 6. Known severe hypersensitivities to medical adhesives or hydrogel, or to one of the chemotherapies used in this trial. 7. Pregnancy or breast-feeding (female patients with reproductive potential and their partners must accept to use effective contraception throughout the entire study period and for 3 months after the end of treatment). All patients who are capable of becoming pregnant must take a pregnancy test which is negative within 72 hours before beginning treatment. The definition of effective contraception is left up to the decision of the investigator. 8. Unable to follow the protocol for medical, psychological, familial, geographic or other reasons. 9. Admitted to an institution by administrative or court order.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pancreas adenocarcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pancreatic adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pancreas adenocarcinoma

Contacts and locations

Locations

  • A.O. SS Antonio e Biagio e Cesare Arrigo

    Alessandria, 15121, Italy

  • A.O.U Città della Salute e della Scienza di Torino

    Torino, 10126, Italy

  • Accelerium S de RL de C.V.

    Monterrey, Nuevo León, 64000, Mexico

  • AdventHealth Neuro Oncology

    Orlando, Florida, 32804, United States

  • Adventist Health St. Helena - Martin-O'Neil Cancer Center (MOCC)

    St. Helena, California, 94574, United States

  • Ajou University Hospital

    Suwon, 16499, South Korea

  • Arizona Oncology Associates, PC- HOPE - US Oncology Research

    Tucson, Arizona, 85711, United States

  • Associated Neurologists of Southern Connecticut, P.C.

    Milford, Connecticut, 06460, United States

  • Astera Cancer Care

    East Brunswick, New Jersey, 08816, United States

  • Azienda Ospedaliero-Universitaria Careggi

    Florence, 50134, Italy

  • BRCR Medical Center INC

    Plantation, Florida, 33324, United States

  • Bacs-Kiskun County Hospital

    Kecskemét, 6000, Hungary

  • Banner MD Anderson Cancer Center

    Gilbert, Arizona, 85234, United States

  • Bassett Medical Center

    Cooperstown, New York, 13326, United States

  • Baylor Scott and White Medical Center

    Temple, Texas, 76508, United States

  • Beijing Cancer Hospital

    Beijing, 100142, China

  • Bekes County Hospital

    Gyula, 5700, Hungary

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215, United States

  • Boca Raton Regional Hospital, Lynn Cancer Institute

    Boca Raton, Florida, 33486, United States

  • Bonifatius Hospital Hematology and Oncology

    Lingen, 49808, Germany

  • CHA Bundang Medical Center, CHA University

    Seongnam-si, South Korea

  • Cancer Specialist of North Florida

    Fleming Island, Florida, 32003, United States

  • Cancer and Hematology Centers of Western Michigan, PC

    Grand Rapids, Michigan, 49503, United States

  • Carl-von-Basedow-klinikum Saalekrei

    Merseburg, 06217, Germany

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048, United States

  • Central Maine Medical Center, Clinical Research Department

    Lewiston, Maine, 04240, United States

  • Centre Hospitalier Universitaire de Sherbrooke CIUSSS de l'Estrie - CHUS

    Sherbrooke, Quebec, J1G 1B1, Canada

  • Centre Hospitalier de Bretagne Sud /Site du Scorff

    Lorient, 56322, France

  • Centre Hospitalier de I'Universitaire de de Montreal (CHUM)

    Montreal, Quebec, H2X 3E4, Canada

  • Centre Léon Bérard

    Lyon, France

  • Centre de Lutte Contre le Cancer (CLCC) - Centre Paul Strauss

    Strasbourg, 67000, France

  • Centro Hemato-Oncologico Privado CHOP

    Toluca, 50080, Mexico

  • Centro Potosino de Investigación Médica SC,

    San Luis Potosí City, 78250, Mexico

  • Centro de Estudios de Alta Especialidad de Sinaloa, ubicado

    Mazatlán, Sinaloa, 82110, Mexico

  • Centro de Investigación Médica Aguascalientes (CIMA),

    Aguascalientes, 20116, Mexico

  • Centro de Pesquisa Clínica e Ensino Florianópolis LTDA

    Florianópolis, 88020, Brazil

  • Centrum Medyczne MrukMed

    Rzeszów, 35-021, Poland

  • Chonnam National University Hwasun Hospital

    Hwasun, 58128, South Korea

  • Clinica Universiatria de Navarra

    Pamplona, 31008, Spain

  • Clinique Sainte Anne - Groupe Hospitalier Saint-Vincent, Strasbourg Oncologie Libérale

    Strasbourg, 67000, France

  • Clinique Universutaire Saint Luc - Institut Roi Albert II

    Woluwe-Saint-Lambert, 1200, Belgium

  • Clinstile S.A. de C.V.,

    Cuauhtémoc, 06700, Mexico

  • Clínica OncoStar - REDE D´OR

    São Paulo, 04543, Brazil

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada, 89619, United States

  • Cotton O'Neil Cancer Center (Stormont-Vail Cancer Center)

    Topeka, Kansas, 66606, United States

  • Dignity Health - Mercy Cancer Centers

    Sacramento, California, 95816, United States

  • Dong-A University Hospital

    Seogu, Busan, 602-715, South Korea

  • FAICIC Clinical Research

    Veracruz, 91900, Mexico

  • Faculté de Médecine Campus Erasme

    Anderlecht, 1070, Belgium

  • Florida Cancer Specialists

    St. Petersburg, Florida, 33705, United States

  • Florida Cancer Specialists & Research Institute - Colonial Office

    Fort Myers, Florida, 33905, United States

  • Florida Hospital Tampa

    Tampa, Florida, 33613, United States

  • Gabrail Cancer Research Center

    Canton, Ohio, 44718, United States

  • Gachon University Gil Hospital

    Incheon, 21565, South Korea

  • Geisinger Medical Center

    Danville, Pennsylvania, 17822, United States

  • General University Hospital in Prague

    Prague, 128 08, Czechia

  • Grandview Medical Center, Cancer Center

    Birmingham, Alabama, 35243, United States

  • Greenslopes Private Hospital

    Greenslopes, Queensland, 4120, Australia

  • Groupo Clinicas Oncologicas Integradas (COI) - Barra da Tijuca

    Rio de Janeiro, 22775-001, Brazil

  • Guangdong provincial people's hospital

    Guangzhou, 510000, China

  • HM Hospitales - Centro Integral Oncologico Clara Campal - CIOCC

    Madrid, 28050, Spain

  • Hadassah Medical Center

    Jerusalem, 9112000, Israel

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, 150086, China

  • Henan Provincial Peoples Hospital

    Zhengzhou, China

  • Hopital haut-Léveque CHU Bordeaux - Service d'Hépato- Gastroentérologie et d'Oncologie digestive

    Pessac, Bordeaux, 33604, France

  • Hospital Angeles San Luis

    San Luis Potosí City, 78200, Mexico

  • Hospital General Universitario de Elche

    Elche, Spain

  • Hospital Regional Universitario de Málaga

    Málaga, 29010, Spain

  • Hospital São Lucas da PUCRS

    Porto Alegre, 90610, Brazil

  • Hospital Universitario Marqués de Valdecilla

    Santander, Spain

  • Hospital Universitario Ramon Y Cajal Carretera de Colmenar Viejo

    Madrid, Spain

  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, 90035, Brazil

  • Hospitales Star Medica - Luna Parc

    Estado de México, 54750, Mexico

  • Houston Methodist Cancer Center

    Houston, Texas, 77030, United States

  • Hôpital Privé des Côtes d'Armor

    Plérin, 22190, France

  • Hôpital Fribourgeois/Freiburger Spital

    Fribourg, 1708, Switzerland

  • IRPCc - Instituto Ribeirãopretano de Combate ao Câncer

    Ribeirão Preto, 14015-130, Brazil

  • Illinois Cancer Specialist - US Oncology Research

    Arlington Heights, Illinois, 60005, United States

  • Infirmary Cancer Care

    Mobile, Alabama, 36607, United States

  • Inha University Hospital

    Incheon, 22332, South Korea

  • Institut de Cancérologie de l'Ouest

    Saint-Herblain, 44805, France

  • Instituto D'Or de Pesquisa e Ensino - Rio De Janeiro

    Rio de Janeiro, 22271, Brazil

  • Instituto D´Or de Pesquisa e Ensino - Hospital São Rafael

    São Marcos, 41253-190, Brazil

  • Instituto Oncòlogico Dr. Rosell

    Barcelona, 08028, Spain

  • Instituto Valenciano de Oncología IVO

    Valencia, 46009, Spain

  • Irmandade da Santa Casa de Misericórdia de Porto Alegre

    Porto Alegre, 90020-090, Brazil

  • Jan Mikulicz-Radecki University Teaching Hospital

    Wroclaw, 50-556, Poland

  • Jasz-Nagykun-Szolnok County Hospital

    Szolnok, 5000, Hungary

  • Jilin Guowen Hospital

    Jilin City, 136100, China

  • KS Winterthur

    Winterthur, 8401, Switzerland

  • Kaleida Health

    Buffalo, New York, 14210, United States

  • Karmanos Cancer Institute

    Detroit, Michigan, 48201, United States

  • Keimyung University, Dongsan hospital

    Daegu, 42601, South Korea

  • Klinikum Chemnitz gGmbH

    Chemnitz, 09116, Germany

  • Klinikum Klagenfurt am Wörthersee

    Klagenfurt, Wörthersee, 9020, Austria

  • Klinikum München Bogenhausen, Klinik für Gastroenterologie und Gastroenterologische Onkologie

    München, 81925, Germany

  • Korea University Guro Hospital

    Seoul, 08308, South Korea

  • Landes-Krankenhaus Steyr

    Steyr, 4400, Austria

  • Linyi Cancer Hospital

    Linyi, Shandong, 276000, China

  • London Regional Cancer Program, London Health Sciences Centre

    London, Ontario, N6A 5W9, Canada

  • Loyola University Medical Center

    Maywood, Illinois, 60153, United States

  • Maryland Oncology Hematology, P.A - US Oncology Research

    Columbia, Maryland, 21044, United States

  • Masaryk Institute of Oncology

    Brno-střed, 60200, Czechia

  • Mayo Clinic Hospital - Florida

    Jacksonville, Florida, 32224, United States

  • Mediadvance Clinical

    Chihuahua City, Chih., 31210, Mexico

  • Medical University Graz

    Graz, 17070, Austria

  • Medizinische Hochschule Hannover, Klinik fur Gastroenterologie, Hepatologie und Endokrinologie

    Hanover, Germany

  • Methodist Regional Cancer Center

    Dallas, Texas, 75203, United States

  • MidAmerica Division

    Kansas City, Missouri, 64132, United States

  • Monash Medical Centre

    Clayton, VIC 3168, Australia

  • Mount Sinai Medical Center

    Miami Beach, Florida, 33140, United States

  • NYU Langone Arena Oncology

    Lake Success, New York, 11042, United States

  • National Cancer Center

    Gyeonggi-do, 10408, South Korea

  • National Institute of Oncology

    Budapest, 1122, Hungary

  • Nebraska Methodist Hospital

    Omaha, Nebraska, 68114, United States

  • Nemocnice Na Bulovce

    Prague, 180 81, Czechia

  • Nemocnice Nový Jičín

    Nový Jičín, 741 01, Czechia

  • New York Hospital Queens

    Flushing, New York, 11355, United States

  • NorthShore University HealthSystem

    Evanston, Illinois, 60201, United States

  • Norton Cancer Institute, Norton Healthcare Pavilion

    Louisville, Kentucky, 40202, United States

  • Novant Health Oncology Specialists

    Winston-Salem, North Carolina, 27103, United States

  • Núcleo de Pesquisa Clínica da Rede São Camilo

    São Paulo, 04014-002, Brazil

  • Ochsner Medical Center

    New Orleans, Louisiana, 70121, United States

  • Oncocenter - Puebla

    Puebla City, 72530, Mexico

  • Oncoclinicas Group Botafogo

    Rio de Janeiro, 22250-040, Brazil

  • Oncology Clinic Clinical Hospital of Przemienienia Pańskiego UM in Poznaniu

    Poznan, 60-596, Poland

  • Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care - US Oncology Research

    Roanoke, Virginia, 24014, United States

  • Oncology and Radiotherapy Clinic University Clinical Center Non-Invasive Medicine Center

    Warsaw, 02-507, Poland

  • Oncology and Radiotherapy Clinic, Oncology Center - Institute

    Warsaw, 02-034, Poland

  • Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda

    Ijuí, 98700, Brazil

  • OptumCare Cancer Care

    Las Vegas, Nevada, 89102, United States

  • Ospedale San Giovanni Calibita Fatebenefratelli Isola Tiberina

    Roma, 00186, Italy

  • Pacific Cancer Medical Center

    Anaheim, California, 92801, United States

  • Peking Union Medical College Hospital

    Beijing, China

  • Peking University People'S Hospital

    Beijing, China

  • Phylasis Clinicas Research S. de R.L. de C.V.

    Cuautitlán Izcalli, 54769, Mexico

  • Phylasis Clinicas Research S.de R.L. de C.V. (PCR)-Toluca

    Toluca, 50180, Mexico

  • Piedmont Cancer Institute

    Atlanta, Georgia, 30318, United States

  • Providence Medical Foundation

    Fullerton, California, 92835, United States

  • Queen Mary Hospital

    Hong Kong, Hong Kong

  • Rabin Medical Center

    Petah Tikva, 4941492, Israel

  • Rambam Health Care Campus, Oncology Institute

    Haifa, 3109601, Israel

  • Renown Regional Medical Center & Renown Institute for Cancer

    Reno, Nevada, 89502, United States

  • Ridley-Tree Cancer Center

    Santa Barbara, California, 93105, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • Saint Elizabeth Healthcare

    Edgewood, Kentucky, 41017, United States

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Seattle Cancer Care Alliance

    Seattle, Washington, 98109, United States

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 13620, South Korea

  • Service d'Oncologie médicale du Pr. Andre, Hôpital Saint-Antoine

    Paris, 75012, France

  • Severance Hospital, Yonsei University Health System

    Seoul, 03722, South Korea

  • Shanghai Changhai Hospital

    Shanghai, 200433, China

  • Shanxi Provincial Cancer Hospital

    Shanxi, 030013, China

  • Sheba Pancreatic Cancer Center - SPCC

    Ramat Gan, Israel

  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

  • Sourasky Medical Center, Oncology Department

    Tel Aviv, 64239, Israel

  • St. John of God Murdoch Hospital

    Murdoch, Western Australia, 6150, Australia

  • Sun Yat-sen Memorial Hospital Sun Yat-sen University

    Guangzhou, Guangdong, 510000, China

  • Sutter Cancer Center Sacramento

    Sacramento, California, 95816, United States

  • Sydney Adventist Hospital

    Wahroonga, NSW 2076, Australia

  • Tennessee Cancer Specialists

    Knoxville, Tennessee, 37909-1327, United States

  • Tennessee Oncology

    Nashville, Tennessee, 37203, United States

  • Texas Oncology - Baylor - US Oncology Research

    Dallas, Texas, 75246, United States

  • Texas Oncology - Beaumont Mamie McFaddin Ward Cancer Center - US Oncology Research

    Beaumont, Texas, 77702, United States

  • Texas Oncology - Bedford - US Oncology Reasearch

    Bedford, Texas, 76022, United States

  • Texas Oncology - El Paso Cancer Treatment Center Gateway - US Oncology Research

    El Paso, Texas, 79915, United States

  • Texas Oncology - Tyler - US Oncology Research

    Tyler, Texas, 75702, United States

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    Seoul, 06591, South Korea

  • The First Affiliated Hospital of Xi 'an Jiaotong University

    Xi'an, Shaanxi, 710061, China

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, 450052, China

  • The first hospital of Jilin University

    Changchun, 130021, China

  • Toledo Clinic Cancer Centers

    Toledo, Ohio, 44614, United States

  • Tolna County Hospital

    Szekszárd, 7100, Hungary

  • Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology

    Wuhan, Hubei, 430014, China

  • UMass Memorial Medical Center

    Worcester, Massachusetts, 01605, United States

  • UT/Erlanger Oncology & Hematology

    Chattanooga, Tennessee, 37403, United States

  • UZ Leuven

    Leuven, 3000, Belgium

  • Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology

    Wuhan, Hubei, 430000, China

  • Univ. Klinik für Innere Medizin III der PMU

    Salzburg, 5020, Austria

  • Universidad Autonoma de Nuevo Leon - Hospital Universitario "Dr. Jose Eleuterio Gonzalez"

    Monterrey, 64460, Mexico

  • University Hospital Centre Zagreb

    Zagreb, 10000, Croatia

  • University Hospital Olomouc

    Olomouc, 779 00, Czechia

  • University of Arizona Cancer Center

    Tucson, Arizona, 85724-5024, United States

  • University of Kansas Medical Cancer Center

    Fairway, Kansas, 66205, United States

  • University of Maryland Comprehensive Cancer Center

    Baltimore, Maryland, 21201, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, 73104, United States

  • Università Campus Bio-Medico di Rome

    Roma, 00128, Italy

  • Universitätsklinikum Ulm

    Ulm, D-89081, Germany

  • VK und K Studien GbR Landshut-Achdorf

    Landshut, 84036, Germany

  • Vall d´Hebron University Hospital

    Barcelona, Spain

  • Virginia Mason Medical Center

    Seattle, Washington, 98101, United States

  • Vista Oncology Inc PS

    Olympia, Washington, 98506, United States

  • Vita Medical Associates, P.C.

    Fountain Hill, Pennsylvania, 18015, United States

  • West Virginia University Cancer Institute

    Morgantown, West Virginia, 26506, United States

  • Westmead Hosptial

    Westmead, NSW 2145, Australia

  • White Plains Hospital - Center for Cancer Care

    White Plains, New York, 10601, United States

  • Willamette Valley Cancer Institute and Research Center - US Oncology Research

    Eugene, Oregon, 97401, United States

  • Xingtai People's Hospital

    Xingtai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.